Clinical Trial: NCT03904134
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
Status:
COMPLETEDPhase:
Not Applicable| Lead Sponsor: | Center for International Blood and Marrow Transplant Research |
| Information Provided By: | Center for International Blood and Marrow Transplant Research |
| Last Update Posted: | 2026-01-05 |
Study Overview
Brief Summary
The purpose of this study is to determine if a search strategy of searching for an HLA-matched unrelated donor for allogeneic transplantation if possible then an alternative donor if an HLA-matched unrelated donor is not available versus proceeding directly to an alternative donor transplant will result in better survival for allogeneic transplant recipients within 2 years after study enrollment.
Official Title
Conditions
Intervention / Treatment
- Other: Donor Search Prognosis Score
Other Study ID Numbers
- BMT CTN 1702
- 5U24HL138660-02
- N00014-18-1-2888
Start Date (Actual)
Primary Completion Date (Actual)
Study Completion Date (Actual)
Enrollment (Actual)
Study Type
Phase
| Lead Sponsor: | Center for International Blood and Marrow Transplant Research |
| Information Provided By: | Center for International Blood and Marrow Transplant Research |
| Last Update Posted: | 2026-01-05 |
Study Overview
Brief Summary
The purpose of this study is to determine if a search strategy of searching for an HLA-matched unrelated donor for allogeneic transplantation if possible then an alternative donor if an HLA-matched unrelated donor is not available versus proceeding directly to an alternative donor transplant will result in better survival for allogeneic transplant recipients within 2 years after study enrollment.
Official Title
Conditions
Intervention / Treatment
- Other: Donor Search Prognosis Score
Other Study ID Numbers
- BMT CTN 1702
- 5U24HL138660-02
- N00014-18-1-2888